Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

General Cannabis Corp buy Medvey

General Cannabis Corp
Start price
€0.59
04.02.20 / 100%
Target price
€0.70
04.11.21
Performance (%)
-38.81%
End price
€0.36
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €0.36. Massive losses of -38.81% were the result for the BUY prediction by Medvey. Medvey has a follow-up prediction for General Cannabis Corp, but this time predicts that General Cannabis Corp is a Sell. Medvey has 100% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
General Cannabis Corp - - - -
iShares Core DAX® 1.804% -0.748% 13.168% 16.408%
iShares Nasdaq 100 -0.182% -3.412% 39.976% 43.502%
iShares Nikkei 225® 0.413% -7.381% 18.776% 2.874%
iShares S&P 500 0.664% -1.941% 28.141% 42.155%

According to Medvey what are the pros and cons of General Cannabis Corp for the foreseeable future?

Pros
Very Future proof/growth oriented business model
Leading role in innovation
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
Cons

Comments by Medvey for this prediction

In the thread General Cannabis Corp diskutieren
Prediction Buy
Perf. (%) -38.81%
Target price 1.000
Change
Ends at 04.11.21

Buy mit Kursziel 1,0

Medvey 
0
Report Share
04.02.20

https://video.fid-verlag.de/?vlpkit_instance_id=1006&wkz=HNF5069&uwkz=HNF5071&banner=Z1_A135083_M293852710150_T59_IA&bmmailid=3R10GM9J-3QZSBE9Y-LQAE9N&sys=551&scid=YmVsYW1lZHZleUB0LW9ubGluZS5odQ==&utm_source=187000582073&utm_medium=email&tags=_HNF_

Medvey 
0
Report Share
04.02.20 Buy -38.81%
Prediction Buy
Perf. (%) -38.81%
Target price 2.000
Change
Ends at 04.11.21

Kursziel geändert auf 2,0

Medvey 
0
Report Share
15.02.20
Prediction Buy
Perf. (%) -38.81%
Target price 1.000
Change
Ends at 04.11.21

Kursziel geändert auf 1,0

Medvey 
0
Report Share
08.06.20
Prediction Buy
Perf. (%) -38.81%
Target price 2.500
Change
Ends at 04.11.21

Kursziel geändert auf 2,5

Medvey 
0
Report Share
08.06.20
Prediction Buy
Perf. (%) -38.81%
Target price 3.000
Change
Ends at 04.11.21

Kursziel geändert auf 3,0

Medvey 
0
Report Share
08.08.20
Prediction Buy
Perf. (%) -38.81%
Target price 0.000
Change
Ends at 04.11.21

Kursziel geändert auf 0,0

Medvey 
0
Report Share
16.09.20
Prediction Buy
Perf. (%) -38.81%
Target price 1.000
Change
Ends at 04.11.21

Kursziel geändert auf 1,0

Medvey 
0
Report Share
16.09.20
Prediction Buy
Perf. (%) -38.81%
Target price 3.000
Change
Ends at 04.11.21

Kursziel geändert auf 3,0

Medvey 
0
Report Share
15.10.20
Prediction Buy
Perf. (%) -38.81%
Target price 6.000
Change
Ends at 04.11.21

Kursziel geändert auf 6,0

Medvey 
0
Report Share
10.02.21
Prediction Buy
Perf. (%) -38.81%
Target price 0.700
Change
Ends at 04.11.21

Kursziel geändert auf 0,7

Medvey 
0
Report Share
12.10.21
In the thread Trading General Cannabis Corp
Prediction Buy
Perf. (%) -38.81%
Target price 0.700
Change
Ends at 04.11.21

Die von Medvey gewählte maximale Laufzeit wurde überschritten

Medvey 
0
Report Share
05.11.21

Current prediction by Medvey for General Cannabis Corp

sell
General Cannabis Corp

Start price
Target price
Perf. (%)
€0.071
22.07.23
€0.070
22.07.24
38.73%
06.09.23

Very Future proof/growth oriented business model
Leading role in innovation
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
Medvey 
22.07.23 95%

Stopped prediction by Medvey for General Cannabis Corp

buy
General Cannabis Corp

Start price
Target price
Perf. (%)
€0.16
08.12.22
€0.10
08.12.23
-54.49%
22.07.23

Very Future proof/growth oriented business model
Leading role in innovation
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
Medvey 
08.12.22 80%
buy
General Cannabis Corp

Start price
Target price
Perf. (%)
€0.35
13.11.21
€2.00
13.11.22
-47.91%
14.11.22

Very Future proof/growth oriented business model
Leading role in innovation
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
Medvey 
13.11.21 70%